CagriSema Research Kit — Dual GLP-1 receptor agonist + amylin analog combination for advanced metabolic pathway research
CagriSema (Cagrilintide + Semaglutide) is one of the most studied dual-action metabolic research combinations. Cagrilintide (long-acting amylin analog) acts on CGRP/CT receptors for satiety signaling, while Semaglutide (GLP-1 RA) reduces appetite through GLP-1 receptor activation. Studying their combined effects on metabolic pathways, body weight regulation, and glycemic parameters is a major area of current research interest.
Cagrilintide 5mg + Semaglutide 5mg — ideal for initial dual-mechanism metabolic research protocols
Cagrilintide 10mg + Semaglutide 10mg — extended supply for dose-response and combination studies
Cagrilintide 10mg × 2 + Semaglutide 10mg × 2 — comprehensive multi-protocol research supply
Both components independently HPLC verified for purity and identity. Separate COA for each compound.
Research combination kit pricing from $89.99 — significant savings vs buying separately.
Ships within 24–48 hours. Discrete cold-pack packaging with tracked USA delivery on every order.
Both Cagrilintide and Semaglutide include individual COAs with batch traceability.
CagriSema refers to research combining Cagrilintide (amylin/CGRP receptor agonist) and Semaglutide (GLP-1 receptor agonist). Research investigates synergistic metabolic effects of dual GLP-1 + amylin receptor activation on appetite regulation, energy balance, and glucose metabolism pathways in laboratory settings.
Semaglutide primarily activates GLP-1 receptors to slow gastric emptying, reduce glucagon secretion, and modulate appetite. Cagrilintide activates amylin/CGRP receptors with complementary actions on satiety signaling and gastric motility. Combining them in research allows study of additive or synergistic pathways targeting multiple metabolic receptors.
Yes — the CagriSema kit includes individual Certificates of Analysis for both Cagrilintide and Semaglutide, each confirming ≥99% purity via HPLC and providing independent batch traceability for complete research documentation.
Cagrilintide + Semaglutide is a long-acting amylin analog combined with a GLP-1 receptor agonist studied as part of the dual receptor research stack category. It is investigated in pre-clinical and in-vitro research models for its activity on amylin and GLP-1 receptor signaling in metabolic research models. The compound is supplied as a lyophilized powder of ≥99% HPLC-verified purity and is intended exclusively for laboratory research use under qualified scientific supervision.
AscendLabz Cagrilintide + Semaglutide is sourced from cGMP-aligned synthesis facilities and validated for identity, purity, and counter-ion content prior to release. Each lot is independently tested by HPLC, and a Certificate of Analysis (COA) detailing peak area, retention time, and batch number is provided with every order. This level of documentation is intended to support reproducible research and clear chain-of-custody record-keeping in academic and independent laboratory environments.
For research workflows, Cagrilintide + Semaglutide is most commonly characterized in cell-culture and isolated-tissue models where investigators examine dual amylin + GLP-1 receptor engagement alongside complementary compounds in the GLP-1 / amylin research stacks class. Reference standards and dose-response controls should be established by each laboratory prior to experimental use, and all material should be handled by trained personnel using appropriate personal protective equipment.
Storage: Lyophilized vials are stable at -20°C. Reconstituted solutions should be refrigerated at 2-8°C and used within 30 days. Lyophilized peptides should be kept in original sealed packaging until use to prevent moisture uptake.
Reconstitution: Bring the lyophilized vial to room temperature before opening. Reconstitute with bacteriostatic water by injecting solvent down the inner wall of the vial; do not direct the stream onto the lyophilized cake. Gently swirl — do not vortex or shake — until fully dissolved. Allow 5-10 minutes for complete solvation.
Handling: Use sterile technique throughout. Wipe vial septa with isopropyl alcohol before each draw. Document reconstitution date, solvent volume, and resulting concentration on the vial label for traceability.
Every batch of Cagrilintide + Semaglutide is analyzed by reverse-phase HPLC and confirmed to be ≥99% pure. Mass spectrometry confirms molecular identity, and counter-ion / residual-solvent panels are performed where applicable. The full Certificate of Analysis ships with each order and is also archived by lot number.
No. Cagrilintide + Semaglutide is supplied strictly for in-vitro laboratory research and is not approved by the FDA, EMA, or any regulatory authority for human or veterinary therapeutic use. It must not be administered to humans or animals. By purchasing, you confirm you are a qualified researcher and the material will be used only in a controlled laboratory setting.
All orders ship from the USA via tracked courier within 24-48 hours of payment confirmation. Domestic delivery typically arrives within 2-5 business days in discreet, temperature-stable packaging. Tracking is provided by email at the time of dispatch.
AscendLabz prices Cagrilintide + Semaglutide competitively while maintaining ≥99% HPLC-verified purity and a full COA. Bulk-vial bundles offer additional savings for laboratories ordering multi-month research supply. Pricing is reviewed monthly to remain among the most affordable verified-purity sources in the United States.
Cryptocurrency (Bitcoin, Ethereum, USDC, and others) is accepted with automatic discounts at checkout. Credit and debit cards are also supported through our secure payment processor. All transactions are encrypted end-to-end and order details are never shared with third parties.
Yes. Most laboratories order Cagrilintide + Semaglutide together with complementary compounds from the GLP-1 / amylin research stacks category. Combined orders ship together with a single COA package and qualify for bulk-tier pricing. See the related compounds section below for commonly paired research peptides.
Researchers ordering Cagrilintide + Semaglutide frequently study it alongside these related compounds:
⚠️ Research Use Only
All products are strictly for laboratory research purposes only. Not for human consumption. These products have not been approved by the FDA for therapeutic use. For in vitro research and scientific study only.